Yüklüyor......
Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration
PURPOSE: To determine the most cost-effective treatment for patients with newly diagnosed neovascular macular degeneration: monthly or as-needed bevacizumab injections, or monthly or as-needed ranibizumab injections. DESIGN: Cost effectiveness analysis PARTICIPANTS: Hypothetical cohort of 80-year-ol...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109727/ https://ncbi.nlm.nih.gov/pubmed/24405740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2013.10.037 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|